Trial of EXenatide in Acute Ischaemic Stroke "TEXAIS"

Recruiting

Phase 2 Results N/A

Summary of Purpose

Overview: Elevated blood glucose levels are common in many acute diseases, resulting in worse clinical outcomes. Hyperglycaemia in acute ischaemic stroke (post-stroke hyperglycaemia [PSH]) occurs in up to 50% patients, reduces the efficacy of stroke thrombolysis with increased risk of haemorrhage, increases infarct size, and results in worse clinical outcomes and death. Insulin-based therapies have not proved...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 December 2017.

23 Nov 2017 13 Jul 2017 31 Dec 2019 31 Dec 2020 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts